Zomedica delisted from NYSE American, to trade on OTCQB starting March 5 under ZOMDF

Zomedica Corp.

NYSE American suspended trading March 4, 2025 due to low share price under Section 1003(f)(v).
Company expects trading on OTCQB under symbol ZOMDF effective March 5, 2025.
CEO Larry Heaton stated disappointment but emphasized focus on growth and pipeline.
Company will continue to file periodic reports with the SEC and meet regulatory requirements.
Transition does not affect business or operations; real-time trading data remains available via OTC Markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.